Sherven Sharma, Ph.D.
University of California, Los Angeles
|
|
# of Grants: 2 |
Grants
Publications
SLC reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Sharma S, Stolina M, Zhu L, Lin Y, Batra RK, Huang M, Strieter R, and Dubinett SM |
ART |
Yr: 2991 |
Vol: 61 |
Nbr: 17 |
Abs: |
Pg: 6406-12 |
Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. |
Periodical: Journal of Biological Chemistry |
Index Medicus: |
Authors: Dohadwala M, Luo J, Lin Y Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM |
ART |
Yr: 2001 |
Vol: 276 |
Nbr: 24 |
Abs: |
Pg: 20809-12 |
Ectopic expression of the thyroperoxidase gene augments radiolodide uptake and retention mediated by the socium iodide symporter in non-small cell lung cancer. |
Periodical: Proceedings of the National Academy of Sciences of the United States of America |
Index Medicus: |
Authors: Hunag M, Batra RK, Kogai T, Lin YQ, Hershman JM, Lichtenstein A, Sharma S, et al |
ART |
Yr: 2000 |
Vol: 97 |
Nbr: 15 |
Abs: |
Pg: 8519-24 |
SLC/CCL21-mediated anti-tumor responses require IFNy, MIG/CXCL9 and IP-10/CXCL10. |
Periodical: Molecular Cancer Research |
Index Medicus: |
Authors: Sharma S, Yang SC, Hillinger S, Zhu L, Huang M, Batra RK, Lin JF, Burdick MD, et al |
ART |
Yr: 2003 |
Vol: 2 |
Nbr: 1 |
Abs: |
Pg: 22 |
Tumor COX-2 dependent regulation of murine dendritic cell function. |
Periodical: Clinical Cancer Research |
Index Medicus: |
Authors: Sharma S, Stolina M, Baratelli F, Lin JF, Atianzar K, Zhu L, Lin Y, et al |
ART |
Yr: 2003 |
Vol: 9 |
Nbr: |
Abs: |
Pg: 961-968 |
Non-small cell lung cancer-derived soluble mediators enhance apoptosis in T lymphocytes through an I kappa B kinase-dependent mechanism. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Batra R, Lin Y, Gardner B, Luo J, Dohadwala M, Sharma S, Dubinett SM |
ART |
Yr: 2003 |
Vol: 63 |
Nbr: |
Abs: |
Pg: 642-646 |
Abnormal IL-10Ralpha expression contributes to the maintenance of elevated COX-2 in non-small cell lung cancer cells. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Heuze-Vourc'h N, Krysan K, Batra RK, Sharma S, Dubinett SM |
ART |
Yr: 2003 |
Vol: 63 |
Nbr: |
Abs: |
Pg: 766-770 |
IL-10 mediates the sigma receptor-dependent suppression of antitumor immunity. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Zhu LX, Sharma S, Gardner B, Escuadro B, Atianzar K, Tashkin D, Dubinett SM |
ART |
Yr: 2003 |
Vol: 170 |
Nbr: |
Abs: |
Pg: 3585-3591 |
Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Sharma S, Stolina M, Luo J, Strieter RM, Burdick M, Zhu LI, Batra RK, Dubinett SM |
ART |
Yr: 2000 |
Vol: 164 |
Nbr: |
Abs: |
Pg: 4558 - 4563 |
Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Sharma S, Stolina M, Zhu L, Lin Y, Batra R, Huang M Strieter R, Dubinett SM |
ART |
Yr: 2001 |
Vol: 1;61 |
Nbr: 17 |
Abs: |
Pg: 6406 - 6412 |
Over expression of CCL-21/Secondary lymphoid tissue chemokine in human dendritic cells augments patacrine chemotactic activities for lymphocytes and antigen presenting cells. |
Periodical: Molecular Cancer Research |
Index Medicus: |
Authors: Sharma S, Riedl K, Baratelli F, Batra RK, Yang SC, Luo J, Escuadro B, Figlin R, et al. |
ART |
Yr: 2003 |
Vol: 2 |
Nbr: |
Abs: |
Pg: 35 |
Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer. |
Periodical: Methods in Molecular Medicine |
Index Medicus: |
Authors: Sharma S, Huang M, Dohadwala M, Pold M, Batra RK, Dubinett SM, et al. |
ART |
Yr: 2003 |
Vol: 75 |
Nbr: |
Abs: |
Pg: 723 - 736 |
Intratumoral therapy with cytokine gene-modified dentritic cells in murine lung cancer models. |
Periodical: Methods in Molecular Medicine |
Index Medicus: |
Authors: Sharma S, Yang SC, Batra RK, Dubinett SM |
ART |
Yr: 2003 |
Vol: 75 |
Nbr: |
Abs: |
Pg: 711 - 722 |
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Sharma S, Hillinger S, Yang SC, Zhu L, Huang M Duckett R, Atianzar K, Batra RK, et al. |
ART |
Yr: 2003 |
Vol: 171 |
Nbr: 12 |
Abs: |
Pg: 6457 - 6465 |
Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. |
Periodical: Human Gene Therapy |
Index Medicus: |
Authors: Sharma S, Batra RK, Yang SC, Hillinger S, Zhu L, Atianzar K, Strieter RM, et al |
ART |
Yr: 2003 |
Vol: 14 |
Nbr: 16 |
Abs: |
Pg: 1511 - 1524 |
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. |
Periodical: Clinical Cancer Research |
Index Medicus: |
Authors: Sharma S, Stolina M, Yang SC, Baratelli F, Lin JF, Atianzar K, Luo J, Zhu L, Lin Y, et al. |
ART |
Yr: 2003 |
Vol: 9 |
Nbr: 3 |
Abs: |
Pg: 961 - 968 |
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. |
Periodical: Clinical Cancer Research |
Index Medicus: |
Authors: Sharma S, Yang SC, Hillinger S, Riedl K, Zhang L, Zhu L, Huang M, Atianzar K, et al. |
ART |
Yr: 2004 |
Vol: 10 |
Nbr: 8 |
Abs: |
Pg: 2891 - 2901 |
Tumor COX-2/PGE2 dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Zhang L, Huang M, et al. |
ART |
Yr: 2005 |
Vol: 65 |
Nbr: 14 |
Abs: |
Pg: 6275 - 6281 |
COX-2 inhibition promotes IFNy-dependent enhancement of anti-tumor immunity. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Sharma S, Zhu L, Hillinger S, Yang SC, Gardner B, Kuo B, Reckamp K. Strieter RM, et al. |
ART |
Yr: 2005 |
Vol: 175 |
Nbr: 2 |
Abs: |
Pg: 813 - 819 |
PGE2 induces FOXP3 gene expression and T regulatory function in human CD4+ T cells. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Sharma S, Baratelli F, Lin Y, Zhu L, Yang SC, Heuze-Voure'h N, Zeng G, et al. |
ART |
Yr: 2005 |
Vol: 175 |
Nbr: 3 |
Abs: |
Pg: 1483 - 1490 |
CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. |
Periodical: Annals of the New York Academy of Sciences |
Index Medicus: |
Authors: Sharma S, Strieter RM, Belperio JA, Burdick MD, Dubinett SM Keane MP |
ART |
Yr: 2004 |
Vol: 1028 |
Nbr: |
Abs: |
Pg: 351 - 360 |
SLC reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Sharma S, Stolina M, Zhu L, Lin Y, Batra RK, Huang M, Strieter R, and Dubinett SM |
ART |
Yr: 2991 |
Vol: 61 |
Nbr: 17 |
Abs: |
Pg: 6406-12 |
Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. |
Periodical: Journal of Biological Chemistry |
Index Medicus: |
Authors: Dohadwala M, Luo J, Lin Y Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM |
ART |
Yr: 2001 |
Vol: 276 |
Nbr: 24 |
Abs: |
Pg: 20809-12 |
Ectopic expression of the thyroperoxidase gene augments radiolodide uptake and retention mediated by the socium iodide symporter in non-small cell lung cancer. |
Periodical: Proceedings of the National Academy of Sciences of the United States of America |
Index Medicus: |
Authors: Hunag M, Batra RK, Kogai T, Lin YQ, Hershman JM, Lichtenstein A, Sharma S, et al |
ART |
Yr: 2000 |
Vol: 97 |
Nbr: 15 |
Abs: |
Pg: 8519-24 |
SLC/CCL21-mediated anti-tumor responses require IFNy, MIG/CXCL9 and IP-10/CXCL10. |
Periodical: Molecular Cancer Research |
Index Medicus: |
Authors: Sharma S, Yang SC, Hillinger S, Zhu L, Huang M, Batra RK, Lin JF, Burdick MD, et al |
ART |
Yr: 2003 |
Vol: 2 |
Nbr: 1 |
Abs: |
Pg: 22 |
Tumor COX-2 dependent regulation of murine dendritic cell function. |
Periodical: Clinical Cancer Research |
Index Medicus: |
Authors: Sharma S, Stolina M, Baratelli F, Lin JF, Atianzar K, Zhu L, Lin Y, et al |
ART |
Yr: 2003 |
Vol: 9 |
Nbr: |
Abs: |
Pg: 961-968 |
Non-small cell lung cancer-derived soluble mediators enhance apoptosis in T lymphocytes through an I kappa B kinase-dependent mechanism. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Batra R, Lin Y, Gardner B, Luo J, Dohadwala M, Sharma S, Dubinett SM |
ART |
Yr: 2003 |
Vol: 63 |
Nbr: |
Abs: |
Pg: 642-646 |
Abnormal IL-10Ralpha expression contributes to the maintenance of elevated COX-2 in non-small cell lung cancer cells. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Heuze-Vourc'h N, Krysan K, Batra RK, Sharma S, Dubinett SM |
ART |
Yr: 2003 |
Vol: 63 |
Nbr: |
Abs: |
Pg: 766-770 |
IL-10 mediates the sigma receptor-dependent suppression of antitumor immunity. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Zhu LX, Sharma S, Gardner B, Escuadro B, Atianzar K, Tashkin D, Dubinett SM |
ART |
Yr: 2003 |
Vol: 170 |
Nbr: |
Abs: |
Pg: 3585-3591 |
Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Sharma S, Stolina M, Luo J, Strieter RM, Burdick M, Zhu LI, Batra RK, Dubinett SM |
ART |
Yr: 2000 |
Vol: 164 |
Nbr: |
Abs: |
Pg: 4558 - 4563 |
Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Sharma S, Stolina M, Zhu L, Lin Y, Batra R, Huang M Strieter R, Dubinett SM |
ART |
Yr: 2001 |
Vol: 1;61 |
Nbr: 17 |
Abs: |
Pg: 6406 - 6412 |
Over expression of CCL-21/Secondary lymphoid tissue chemokine in human dendritic cells augments patacrine chemotactic activities for lymphocytes and antigen presenting cells. |
Periodical: Molecular Cancer Research |
Index Medicus: |
Authors: Sharma S, Riedl K, Baratelli F, Batra RK, Yang SC, Luo J, Escuadro B, Figlin R, et al. |
ART |
Yr: 2003 |
Vol: 2 |
Nbr: |
Abs: |
Pg: 35 |
Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer. |
Periodical: Methods in Molecular Medicine |
Index Medicus: |
Authors: Sharma S, Huang M, Dohadwala M, Pold M, Batra RK, Dubinett SM, et al. |
ART |
Yr: 2003 |
Vol: 75 |
Nbr: |
Abs: |
Pg: 723 - 736 |
Intratumoral therapy with cytokine gene-modified dentritic cells in murine lung cancer models. |
Periodical: Methods in Molecular Medicine |
Index Medicus: |
Authors: Sharma S, Yang SC, Batra RK, Dubinett SM |
ART |
Yr: 2003 |
Vol: 75 |
Nbr: |
Abs: |
Pg: 711 - 722 |
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Sharma S, Hillinger S, Yang SC, Zhu L, Huang M Duckett R, Atianzar K, Batra RK, et al. |
ART |
Yr: 2003 |
Vol: 171 |
Nbr: 12 |
Abs: |
Pg: 6457 - 6465 |
Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. |
Periodical: Human Gene Therapy |
Index Medicus: |
Authors: Sharma S, Batra RK, Yang SC, Hillinger S, Zhu L, Atianzar K, Strieter RM, et al |
ART |
Yr: 2003 |
Vol: 14 |
Nbr: 16 |
Abs: |
Pg: 1511 - 1524 |
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. |
Periodical: Clinical Cancer Research |
Index Medicus: |
Authors: Sharma S, Stolina M, Yang SC, Baratelli F, Lin JF, Atianzar K, Luo J, Zhu L, Lin Y, et al. |
ART |
Yr: 2003 |
Vol: 9 |
Nbr: 3 |
Abs: |
Pg: 961 - 968 |
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. |
Periodical: Clinical Cancer Research |
Index Medicus: |
Authors: Sharma S, Yang SC, Hillinger S, Riedl K, Zhang L, Zhu L, Huang M, Atianzar K, et al. |
ART |
Yr: 2004 |
Vol: 10 |
Nbr: 8 |
Abs: |
Pg: 2891 - 2901 |
Tumor COX-2/PGE2 dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer. |
Periodical: Cancer Research |
Index Medicus: |
Authors: Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Zhang L, Huang M, et al. |
ART |
Yr: 2005 |
Vol: 65 |
Nbr: 14 |
Abs: |
Pg: 6275 - 6281 |
COX-2 inhibition promotes IFNy-dependent enhancement of anti-tumor immunity. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Sharma S, Zhu L, Hillinger S, Yang SC, Gardner B, Kuo B, Reckamp K. Strieter RM, et al. |
ART |
Yr: 2005 |
Vol: 175 |
Nbr: 2 |
Abs: |
Pg: 813 - 819 |
PGE2 induces FOXP3 gene expression and T regulatory function in human CD4+ T cells. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Sharma S, Baratelli F, Lin Y, Zhu L, Yang SC, Heuze-Voure'h N, Zeng G, et al. |
ART |
Yr: 2005 |
Vol: 175 |
Nbr: 3 |
Abs: |
Pg: 1483 - 1490 |
CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. |
Periodical: Annals of the New York Academy of Sciences |
Index Medicus: |
Authors: Sharma S, Strieter RM, Belperio JA, Burdick MD, Dubinett SM Keane MP |
ART |
Yr: 2004 |
Vol: 1028 |
Nbr: |
Abs: |
Pg: 351 - 360 |
Intrapulomonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma |
Periodical: Cancer Research |
Index Medicus: |
Authors: Yang, S.C., Batra, R.K., Hillinger, S., Rekamp, K.L., Strieter, R.M., Dubinett, S., Sharma |
ART |
Yr: 2006 |
Vol: 66 |
Nbr: 6 |
Abs: |
Pg: 3205-13 |
CCl19 reduces tumour burden in a model of advanced lung cancer |
Periodical: British Journal of Cancer |
Index Medicus: |
Authors: Hillinger, S., Yang, S.C., Btra, R.K., Strieter, R.M., Weder, W., Dubinett, S.M, Sharma, S |
ART |
Yr: 2006 |
Vol: 94 |
Nbr: 7 |
Abs: |
Pg: 1029-34 |
Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment |
Periodical: Critical Reviews in Oncology/Hematolgy |
Index Medicus: |
Authors: Lee, J.M., Yanagawa, J., Peebles, K.A., Sharma, S., Mao, J.T., Dubinett, S.M. |
ART |
Yr: 2008 |
Vol: 66 |
Nbr: 3 |
Abs: |
Pg: 208-17 |
Tumor response to combination celecoxib and erlotinib therapy in no-smal cell lung cancer is assocated with a low baseline matrix mettalloproteinase-9 and a decline in serum-soluable E-caderherin |
Periodical: Journal of Thoracic Oncology |
Index Medicus: |
Authors: Reckamp, K.L, Gardner, B.K., Figlin, R.A., Elashoff, D., Kryasan, K., Dohadwala, M., Mao, |
ART |
Yr: 2008 |
Vol: 2 |
Nbr: |
Abs: |
Pg: 117-24 |
Immunolgic Approaches to Lung Cancer Therapy |
Periodical: Lung Cancer |
Index Medicus: |
Authors: Lee, J.M., Dubinett, S.M., Sharma, S. |
ART |
Yr: 2007 |
Vol: 3 Edition |
Nbr: |
Abs: |
Pg: |
Inflammation and lung carcinogenesis: applying new findings in prevention and treatment |
Periodical: Expert Review of Anticancer Therapy |
Index Medicus: |
Authors: Peebles, K.A., Lee, J.M., Mao, J.T., Harza, S., Reckamp, K.L., Krysa, K., Dohadwala, M., |
ART |
Yr: 2007 |
Vol: 7 |
Nbr: 10 |
Abs: |
Pg: 1405-21 |
IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Anderson A,Yang S, Huang M, Zhu L, Kar U, Batra R, Elashoff D;StrieterR;Dubinett S SharmaS |
ART |
Yr: 2009 |
Vol: 182 |
Nbr: 11 |
Abs: |
Pg: 6951-6958 |
Intrapulomonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma |
Periodical: Cancer Research |
Index Medicus: |
Authors: Yang, S.C., Batra, R.K., Hillinger, S., Rekamp, K.L., Strieter, R.M., Dubinett, S., Sharma |
ART |
Yr: 2006 |
Vol: 66 |
Nbr: 6 |
Abs: |
Pg: 3205-13 |
CCl19 reduces tumour burden in a model of advanced lung cancer |
Periodical: British Journal of Cancer |
Index Medicus: |
Authors: Hillinger, S., Yang, S.C., Btra, R.K., Strieter, R.M., Weder, W., Dubinett, S.M, Sharma, S |
ART |
Yr: 2006 |
Vol: 94 |
Nbr: 7 |
Abs: |
Pg: 1029-34 |
Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment |
Periodical: Critical Reviews in Oncology/Hematolgy |
Index Medicus: |
Authors: Lee, J.M., Yanagawa, J., Peebles, K.A., Sharma, S., Mao, J.T., Dubinett, S.M. |
ART |
Yr: 2008 |
Vol: 66 |
Nbr: 3 |
Abs: |
Pg: 208-17 |
Tumor response to combination celecoxib and erlotinib therapy in no-smal cell lung cancer is assocated with a low baseline matrix mettalloproteinase-9 and a decline in serum-soluable E-caderherin |
Periodical: Journal of Thoracic Oncology |
Index Medicus: |
Authors: Reckamp, K.L, Gardner, B.K., Figlin, R.A., Elashoff, D., Kryasan, K., Dohadwala, M., Mao, |
ART |
Yr: 2008 |
Vol: 2 |
Nbr: |
Abs: |
Pg: 117-24 |
Immunolgic Approaches to Lung Cancer Therapy |
Periodical: Lung Cancer |
Index Medicus: |
Authors: Lee, J.M., Dubinett, S.M., Sharma, S. |
ART |
Yr: 2007 |
Vol: 3 Edition |
Nbr: |
Abs: |
Pg: |
Inflammation and lung carcinogenesis: applying new findings in prevention and treatment |
Periodical: Expert Review of Anticancer Therapy |
Index Medicus: |
Authors: Peebles, K.A., Lee, J.M., Mao, J.T., Harza, S., Reckamp, K.L., Krysa, K., Dohadwala, M., |
ART |
Yr: 2007 |
Vol: 7 |
Nbr: 10 |
Abs: |
Pg: 1405-21 |
IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer. |
Periodical: Journal of Immunology |
Index Medicus: |
Authors: Anderson A,Yang S, Huang M, Zhu L, Kar U, Batra R, Elashoff D;StrieterR;Dubinett S SharmaS |
ART |
Yr: 2009 |
Vol: 182 |
Nbr: 11 |
Abs: |
Pg: 6951-6958 |